/주식/PCVX
PCVX

PCVX

USD

Vaxcyte Inc. Common Stock

$34.460-0.670 (-1.907%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$35.130

고가

$35.390

저가

$34.260

거래량

1.06M

기업 기본 정보

시가총액

4.4B

산업

생명공학

국가

United States

거래 통계

평균 거래량

2.50M

거래소

NMS

통화

USD

52주 범위

저가 $27.66현재가 $34.460고가 $121.055

관련 뉴스

GlobeNewswire

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

-- Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 2 Dose-Finding Study of VAX-24 in Healthy Infants; Balance of Data Expected by End of 2025 -- -- Initiated Second and Final

더 보기
Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (NASDAQ:PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today

더 보기
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
Analyst Upgrades

Cantor Fitzgerald Initiates Coverage On Vaxcyte with Overweight Rating

Cantor Fitzgerald analyst Carter Gould initiates coverage on Vaxcyte with a Overweight rating.

더 보기
Cantor Fitzgerald Initiates Coverage On Vaxcyte with Overweight Rating